Wall Street Access Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wall Street Access Asset Management, LLC

  • $263 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Apr 25, 2024
BUY
$705.89 - $766.39 $211,767 - $229,917
300 New
300 $216,000
Q4 2022

Feb 02, 2023
BUY
$705.89 - $766.39 $211,767 - $229,917
300 New
300 $216,000
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $164,505 - $221,652
-300 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $178,536 - $209,528
300 New
300 $209,000

Others Institutions Holding REGN

# of Institutions
1,486
Shares Held
83.9M
Call Options Held
1.29M
Put Options Held
1.47M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $71.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Wall Street Access Asset Management, LLC Portfolio

Follow Wall Street Access Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wall Street Access Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wall Street Access Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email